Does dysregulation of key epigenetic and biochemical pathways occur in postulated vasoactive neuropeptide autoimmune disorders?

Staines, 2004, Overview of an autoimmune theory of endogenous vasoactive neuropeptides, Med Hypotheses, 62, 643, 10.1016/j.mehy.2004.02.008 Hashimoto, 2002, Physiological significance of pituitary adenylate cyclase-activating polypeptide (PACAP) in the nervous system, Yakugaku Zasshi, 122, 1109, 10.1248/yakushi.122.1109 Zhou, 2002, PACAP and its receptors exert pleiotropic effects in the nervous system by activating multiple signalling pathways, Curr Prot Pept Sci, 3, 423, 10.2174/1389203023380576 Krieg, 2003, CpG DNA: trigger of sepsis, mediator of protection, or both?, Scand J Infect Dis, 35, 653, 10.1080/00365540310015999 Pei, 1995, Characterisation of the rat vasoactive intestinal polypeptide receptor gene 5′ region, Biochem J, 308, 719, 10.1042/bj3080719 Lutz, 1999, Structure of the human VIPR2 gene for vasoactive intestinal peptide receptor type 2, FEBS Lett, 458, 197, 10.1016/S0014-5793(99)01135-7 Staines, 2005, Do cytosine–guanine (CpG) fragments modulate autoimmune disorders of endogenous vasoactive neuropeptides?, Med Hypotheses, 65, 370, 10.1016/j.mehy.2005.02.014 Staines D. Treatment and prevention options for postulated autoimmune disorders of endogenous vasoactive neuropeptides. Med Hypotheses; 2005 [in press]. Staines, 2004, Is chronic fatigue syndrome and autoimmune disorder of endogenous neuropeptides, exogenous infection and molecular mimicry, Med Hypotheses, 62, 646, 10.1016/j.mehy.2004.01.012 Sreedharan, 1995, Structure, expression, and chromosomal localisation of the type I human vasoactive intestinal peptide receptor gene, Proc Nat Acad Sci USA, 92, 2939, 10.1073/pnas.92.7.2939 Broad, 1989, Structure and methylation of the human calcitonin/alpha-CGRP gene, Nucleic Acids Res, 17, 6999, 10.1093/nar/17.17.6999 Aino, 1995, Structure of the gene encoding the mouse pituitary adenylate cyclase-activating polypeptide receptor, Gene, 164, 301, 10.1016/0378-1119(95)00391-I Delgado, 2003, Vasoactive intestinal peptide prevents activated microglia-induced neurodegeneration under inflammatory conditions: potential therapeutic role in brain trauma, FASEB J, 17, 1922, 10.1096/fj.02-1029fje Ganea, 2003, Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: players in innate and adaptive immunity, Cell Mol Biol (Noisy-le-grand), 49, 127 Klinman, 2000, Immunotherapeutic applications of CpG-containing oligodeoxynucleotides, Drugs News Perspect, 13, 289 He, 2004, CpG DNA induces class switch DNA recombination by activating human B cells through an innate pathway that requires TLR9 and cooperates with IL-10, J Immunol, 173, 4479, 10.4049/jimmunol.173.7.4479 Hong, 2004, Chloroquine protects mice from challenge with CpG ODN and LPS by decreasing proinflammatory cytokine release, Int Immunopharmacol, 492, 223, 10.1016/j.intimp.2003.12.006 Park, 2003, Chloroquine induces activation of nuclear factor-kappaB and subsequent expression of proinflammatory cytokines by human astroglial cells, J Neurochem, 84, 1266, 10.1046/j.1471-4159.2003.01623.x Yi, 1999, CpG DNA rescues B cells from apoptosis by activating NFkappaB and preventing mitochondrial membrane potential disruption via a chloroquine sensitive pathway, Int Immunol, 11, 2015, 10.1093/intimm/11.12.2015 Bandholtz, 2003, Hsp90 binds CpG oligonucleotides directly: implications for hsp90 as a missing link in CpG signalling and recognition, Cell Mol Life Sci, 60, 422, 10.1007/s000180300035 Staines, 2005, Do vasoactive neuropeptides and heat shock proteins mediate fatigue-related autoimmune disorders?, Med Hypotheses, 64, 539, 10.1016/j.mehy.2004.08.013 Norrholm, 2005, Behavioural effects of local microinfusion of pituitary adenylate cyclase activating polypeptide (PACAP) into the paraventricular nucleus of the hypothalamus (PVN), Regul Pept, 128, 33, 10.1016/j.regpep.2004.12.023 Delgado, 2002, Vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide inhibit the MEKK1/MEK4/JNK signalling pathway in endotoxin-activated microglia, Biochem Biopys Res Commun, 293, 771, 10.1016/S0006-291X(02)00283-8 Falluel-Morel, 2004, Opposite regulation of the mitochondrial apoptotic pathway by C2-cerumide and PACAP through a MAP-kinase-dependent mechanism in cerebellar granule cells, J Neurochem, 91, 1231, 10.1111/j.1471-4159.2004.02810.x Vaudry, 2003, Pituitary adenylate cyclase activating polypeptide prevents C2-ceramide-induced apoptosis of cerebellar granule cells, J Neurochem Res, 72, 303, 10.1002/jnr.10530 Hartfield, 1998, Neurotrophic factors prevent ceramide-induced apoptosis downstream of c-Jun N-terminal kinase activation in PC12 cells, J Neurochem, 71, 161, 10.1046/j.1471-4159.1998.71010161.x Moroo, 1998, Pituitary adenylate cyclase activating polypeptide (PACAP) stimulates mitogen-activated protein kinase (MAPK) in cultured rat astrocytes, Brain Res, 795, 191, 10.1016/S0006-8993(98)00291-1 Falluel-Morel, 2004, Opposite regulation of the mitochondrial apoptotic pathway by C2-ceramide and PACAP through a MAP-kinase-dependent mechanism in cerebellar granule cells, J Neurochem, 91, 1231, 10.1111/j.1471-4159.2004.02810.x Antonawich, 2002, Vasoactive intestinal peptide attenuates cyctochrome c translocation, and apoptosis, in rat hippocampal stem cells, Neurosci Lett, 325, 151, 10.1016/S0304-3940(02)00254-9 Minana, 1995, Prenatal exposure of rats to ammonia impairs NMDA receptor function and affords delayed protection against ammonia toxicity and glutamate neurotoxicity, J Neuropathol Exp Neurol, 54, 644, 10.1097/00005072-199509000-00005 Lee, 2005, Results of investigations of Gulf War veterans, Clin Med, 5, 166, 10.7861/clinmedicine.5-2-166 Caballero-Benitez, 2004, Regulation of glutamate synthesising enzymes by NMDA and potassium in cerebellar cells, Eur J Neurosci, 19, 2030, 10.1111/j.0953-816X.2004.03321.x Moran, 1992, Effect of potassium and N-methyl-d-aspartate on the aspartate aminotransferase activity in cultured cerebellar granule cells, J Neurosci Res, 33, 239, 10.1002/jnr.490330207 Llansola, 2004, Modulation of NMDA receptor function by cyclic AMP in cerebellar neurones in culture, J Neurochem, 91, 591, 10.1111/j.1471-4159.2004.02730.x Yaka, 2003, Pituitary adenylate cyclase activating polypeptide (PACAP(1-38)) enhances N-methyl-d-aspartate receptor function and brain derived neurotrophic factor expression via RACK1, J Biol Chem, 278, 9360, 10.1074/jbc.M209141200 Dziema, 2002, PACAP potentiates L-type calcium channel conductance in suprachiasmatic nucleus neurons by activating the MAPK pathway, J neurophysiol, 88, 1374, 10.1152/jn.2002.88.3.1374 Aoyagi, 2001, Pituitary adenylate cyclase-activating polypeptide enhances Ca(2+)-dependent neurotransmitter release from PC12 cells and cultured cerebellar granule cells without affecting intracellular Ca(2+) mobilisation, Biochem Biophys Res Commun, 286, 646, 10.1006/bbrc.2001.5443 Chen, 2000, Cytological characterisation of a pituitary folliculo-stellate-like cell line, Tpit/F1, with special reference to adenosine triphosphate-mediated neuronal nitric oxide synthase expression and nitric oxide secretion, Endocrinology, 141, 3603, 10.1210/en.141.10.3603 Defer, 2000, Tissue specificity and physiological relevance of various isoforms of adenylyl cyclase, Am J Physiol Renal Physiol, 279, F400, 10.1152/ajprenal.2000.279.3.F400 Nowak, 1999, Adenylyl cyclase-isoforms, regulations and function, Postepy Hig Med Dosw, 53, 147 Chabardes, 1999, Functional properties of Ca2+-inhibitable type 5 and 6 adenylyl cyclases and role of Ca2+ increase in the inhibition of intracellular cAMP content, Cell Signal, 11, 651, 10.1016/S0898-6568(99)00031-5 Mons, 1999, The role Ca2+/calmodulin-stimulable adenylyl cyclases as molecular coincidence detectors in memory formation, Cell Mol Life Sci, 55, 525, 10.1007/s000180050311 Chern, 2000, Regulation of adenylyl cyclase in the central nervous system, Cell Signal, 12, 195, 10.1016/S0898-6568(99)00084-4 Shaked, 2005, Protective autoimmunity: interferon-gamma enables microglia to remove glutamate without evoking inflammatory mediators, J Neurochem, 92, 997, 10.1111/j.1471-4159.2004.02954.x Kuratsune, 2002, Brain regions involved in fatigue sensation: reduced acetylcarnitine uptake in the brain, Neuroimage, 17, 1256, 10.1006/nimg.2002.1260 Yao, 2005, Enhancement of glutamate uptake mediates the neuroprotection exerted by activating group II or III metabotropic glutamate receptors on astrocytes, J Neurochem, 92, 948, 10.1111/j.1471-4159.2004.02937.x Molz, 2005, Neurotoxicity induced by glutamate in glucose-deprived rat hippocampal slices is prevented by GMP, Neurochem Res, 30, 83, 10.1007/s11064-004-9689-0 Figiel, 2000, Pituitary adenylate cyclase-activating polypeptide (PACAP), a neuron-derived peptide regulating glial glutamate transport and metabolism, J Neurosci, 20, 3596, 10.1523/JNEUROSCI.20-10-03596.2000 Cao, 2000, A mutation in the second intracellular loop of the pituitary adenylate cyclase activating polypeptide type I receptor confers constitutive receptor activation, FEBS Lett, 469, 142, 10.1016/S0014-5793(00)01269-2 Rangon CM, Goursaud S, Medja F, et al. VPAC2 receptors mediate VIP-induced neuroprotection against neonatal excitotoxic brain lesions in mice. J Pharmacol Exp Ther 2005 May 4 [pub ahead of print]. Shintani, 2005, Neuroprotective action of endogenous PACAP in cultured rat cortical neurons, Regul Pept, 126, 123, 10.1016/j.regpep.2004.08.014 Dong, 2000, Pituitary adenylate cyclase activating polypeptide ameliorates the damage and inhibits the increase of intracellular calcium concentration in cultured hippocampal neurons induced by glutamate, Sheng Li Xue Bao, 52, 402 Onoue, 2002, Pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide attenuate glutamate-induced nNOS activation and cytotoxicity, Regul Pept, 107, 43, 10.1016/S0167-0115(02)00065-4 Schluter, 2002, CNS region-specific regulation of glial glutamate transporter expression, Eur J Neurosci, 16, 836, 10.1046/j.1460-9568.2002.02130.x Figiel, 2003, Regulation of glial glutamate transporter expression by growth factors, Exp Neurol, 183, 124, 10.1016/S0014-4886(03)00134-1 Kopp, 2001, The pituitary adenylate-cyclase activating polypeptide modulates glutamatergic calcium signalling: investigations on rat suprachiasmatic nucleus neurons, J Neurochem, 79, 161, 10.1046/j.1471-4159.2001.00553.x Suk, 2004, Neuropeptide PACAP inhibits hypoxic activation of brain microglia: a protective mechanism against microglial neurotoxicity in ischemia, Brain Res, 1026, 151, 10.1016/j.brainres.2004.08.017 Rabl, 2002, PACAP inhibits anoxia-induced changes in physiological responses in horizontal cells in the turtle retina, Regul Pept, 109, 71, 10.1016/S0167-0115(02)00189-1 Cummings, 2004, Sudden neonatal death in PACAP-deficient mice is associated with reduced respiratory chemoresponse and susceptibility to apnoea, J Physiol, 555, 15, 10.1113/jphysiol.2003.052514 Wilderman, 1997, Role of PACAP in the relationship between cAMP and opioids in hypoxia-induced pial artery vasodilation, Am J Physiol, 272, H1350 Martinez, 2005, Analysis of the role of the PAC1 receptor in neutrophil recruitment, acute-phase response, and nitric oxide production in septic shock, J Leukoc Biol, 77, 729, 10.1189/jlb.0704432